EUVIMEDEUVIMED entdecken
Fallbericht

Approach to The Patient With Combined Pituitary Hormone Deficiency Due to a Novel Homozygous LHX3 Variant

Sirmen Kızılcan Çetin iD, İbrahim Dikmen iD, Elif Özsu iD, Zehra Aycan, Merih Berberoğlu iD, Zeynep Şıklar iD

Clinical Endocrinology · 2026-12 · 105 (6) · 643-650

DOI: 10.1111/cen.70198 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Endocrinology, online erschienen am 05.08.2026. Verfasst von Sirmen Kızılcan Çetin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Ankara University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: LIM-Homeodomain Proteins, Hypopituitarism, Transcription Factors. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Variants in LHX3, encoding a LIM‐homeodomain transcription factor essential for pituitary and neuronal development, are a rare cause of combined pituitary hormone deficiency (CPHD). Affected patients typically exhibit deficiencies of growth hormone (GH), thyrotropin (TSH), prolactin (PRL), and gonadotropins, often accompanied by cervical spine rigidity or sensorineural hearing loss. Case Description A 4.8‐year‐old boy presented with short stature and central hypothyroidism. Combined deficiencies of GH, TSH, and PRL were documented, while ACTH secretion remained intact. Cranial magnetic resonance imaging showed normal pituitary morphology. Neck mobility and audiological evaluation were unremarkable. Evaluation A targeted next‐generation sequencing panel for panhypopituitarism was non‐diagnostic. Whole‐exome sequencing (WES) was performed at 10.5 years of age.

Results

WES identified a novel homozygous LHX3 c.575 G > A, p.(Arg192His) variant located within the homeodomain. Segregation analysis confirmed parental heterozygosity. A younger sister carrying the same homozygous variant exhibited a similar endocrine phenotype. Growth velocity normalized on recombinant human GH replacement.

Conclusion

This case expands the phenotypic spectrum of LHX3 ‐related CPHD by demonstrating that a homeodomain missense variant may produce isolated endocrine deficiencies without structural, auditory, or motor abnormalities, and underscores the value of serial genetic re‐evaluation in unexplained CPHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LIM-Homeodomain ProteinsHypopituitarismTranscription FactorsHumansMaleChild, PreschoolHomozygoteHuman Growth HormoneFemale

Stichwörter der Autor:innen

LHX3central hypothyroidismcombined pituitary hormone deficiencygrowth hormone deficiencyhypopituitarismtranscription factor

Substanzen

LIM-Homeodomain ProteinsLhx3 proteinTranscription FactorsHuman Growth Hormone

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Ankara University School of Medicine, Ankara, Turkey.

ORCID-Profile: Sirmen Kızılcan Çetin, İbrahim Dikmen, Elif Özsu, Merih Berberoğlu, Zeynep Şıklar

Zitieren

APA

Çetin, S. K., Dikmen, İ., Özsu, E., Aycan, Z., Berberoğlu, M., & Şıklar, Z. (2026). Approach to The Patient With Combined Pituitary Hormone Deficiency Due to a Novel Homozygous LHX3 Variant. Clinical Endocrinology, 105(6), 643-650. https://doi.org/10.1111/cen.70198

Vancouver

Çetin SK, Dikmen İ, Özsu E, Aycan Z, Berberoğlu M, Şıklar Z. Approach to The Patient With Combined Pituitary Hormone Deficiency Due to a Novel Homozygous LHX3 Variant. Clinical Endocrinology. 2026;105(6):643-650. doi:10.1111/cen.70198

BibTeX
@article{etin2026,
  author = {Çetin, Sirmen Kızılcan and Dikmen, İbrahim and Özsu, Elif and Aycan, Zehra and Berberoğlu, Merih and Şıklar, Zeynep},
  title = {Approach to The Patient With Combined Pituitary Hormone Deficiency Due to a Novel Homozygous LHX3 Variant},
  journal = {Clinical Endocrinology},
  year = {2026},
  volume = {105},
  number = {6},
  pages = {643--650},
  doi = {10.1111/cen.70198}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche